Discussion This review evaluates the effect on HR of six approved GLP-1 RAs, categorized into a short-acting sub-class with half-lives of 35 h (exenatide BID and lixisenatide) and a long-acting sub-class with half-lives ranging from 12 h to several days (liraglutide, exenatide LAR, albiglutide and dulaglutide) [16]
6 This variability may help explain why some people fall into the non-responder group
The mechanism works on multiple pathways in your brain and digestive system
Some GLP-1 drugs should not be used for people with a personal or family history of certain types of thyroid cancer
In severe cases of deficiency, our experienced healthcare providers may recommend an initial treatment plan that involves frequent injections, potentially daily or every other day, for one to two weeks
Alternatives for Weight Loss with Gastroparesis If Mounjaro is not the right fit for you due to gastroparesis, you are not out of options